Search Results

You are looking at 1 - 10 of 360 items for :

  • "mortality" x
  • Refine by Access: All content x
Clear All
Open access

Zhen-yu Song, Qiuming Yao, Zhiyuan Zhuo, Zhe Ma, and Gang Chen

Introduction Prostate cancer (PCa) is one of the most common malignant tumors in male. In 2017, American Cancer Society reported 161,360 cases of newly diagnosed PCa, accounting for 20% of male tumors. Furthermore, its incidence and mortality

Open access

Florian Schederecker, Alexander Cecil, Cornelia Prehn, Jana Nano, Wolfgang Koenig, Jerzy Adamski, Tanja Zeller, Annette Peters, and Barbara Thorand

of other chronic diseases. Consequently, these changes may affect mortality and there may be divergent effects in women and men, since men and women have markedly different androgen levels with different sex-specific functions ( 9 , 10 ). Sex hormone

Open access

Enrique Soto-Pedre, Paul J Newey, John S Bevan, and Graham P Leese

health outcomes including cardiovascular disease, cancer, osteoporosis, autoimmune conditions and all-cause mortality ( 1 ). There are little useful data on hyperprolactinaemia and cardiovascular endpoints. Controversy exists as to whether

Open access

Bharat Kumar, Madhukar Mittal, Maya Gopalakrishnan, Mahendra K Garg, and Sanjeev Misra

identify patients at high risk for developing severe COVID-19 manifestations and mortality like advanced age, male sex, obesity, hyperglycemia, and presence of comorbidities (diabetes mellitus (DM), cardiovascular disease (CVD) and chronic kidney disease

Open access

Clara Lundetoft Clausen, Åse Krogh Rasmussen, Trine Holm Johannsen, Linda Maria Hilsted, Niels Erik Skakkebæk, Pal Bela Szecsi, Lise Pedersen, Thomas Benfield, and Anders Juul

clinical course and survival of patients admitted with moderate to severe COVID-19 infection by exploring (1) the difference in clinical characteristics and mortality between patients with and without decreased serum TSH concentration, respectively, (2) the

Open access

Yu Ah Hong, Kyung-Do Han, Jae-Seung Yun, Eun Sil Sil, Seung-Hyun Ko, and Sungjin Chung

glucose level ≥126 mg/dL. All participants visited outpatient or inpatient care, were diagnosed with type 2 DM, and accepted at least one prescription of anti-diabetic drugs. The primary endpoint was newly diagnosed ESRD or all-cause mortality during the

Open access

Erika Biegelmeyer, Iury Scanagata, Laura Alves, Murilo Reveilleau, Fernando Pereira Schwengber, and Simone Magagnin Wajner

). Maldonado et al. described lower mean T3 levels in short-term non-survivors among critically ill patients (34 vs 60 ng/dL, P < 0.001) ( 18 ). Liu et al. found that 30-day mortality among patients admitted due to community-acquired pneumonia was higher

Open access

Anastasia P Athanasoulia-Kaspar, Matthias K Auer, Günter K Stalla, and Mira Jakovcevski

length might be linked to the increased morbidity and mortality observed for both diseases ( 16 , 17 ). To the best of our knowledge, studies examining the TL in patients with non-functioning pituitary adenomas (NFPA), characterized by a high incidence

Open access

Zhou-Qing Kang, Jia-Ling Huo, and Xiao-Jie Zhai

controlled trial (RCT) in 2001, which has proved the obvious effects of intensive insulin therapy (IIT, maintain blood glucose at a level no higher than 110 mg/dL) on the reduced morbidity and mortality among critically ill patients after surgery ( 7 ). This

Open access

Yongli Fu, Yaowu Sun, Jiankun Zhang, and Yu Cheng

this topic. Numerous studies have reported that dysglycemia including hyperglycemia, hypoglycemia or serum blood fluctuation is an independent risk factor of mortality for critically ill patients, especially for those with diabetes mellitus ( 1 , 2